Skip to main content
Robert Siegel, MD, Oncology, Washington, DC, George Washington University Hospital

RobertStevenSiegelMD

Oncology Washington, DC

Hematologic Oncology

Professor, Medicine, G Washington University School of Medicine & Hlth Sci

Overview of Dr. Siegel

Dr. Robert Siegel is an oncologist in Washington, DC and is affiliated with multiple hospitals in the area, including George Washington University Hospital and MedStar Georgetown University Hospital. He received his medical degree from George Washington University School of Medicine and has been in practice 40 years. Dr. Siegel accepts several types of health insurance, listed below. He is one of 93 doctors at MedStar Georgetown University Hospital and one of 37 doctors at George Washington University Hospital who specialize in Oncology. He has more than 40 publications and over 300 citings.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1980 - 1982
  • Duke University Hospital
    Duke University HospitalResidency, Internal Medicine, 1977 - 1980
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1977

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1992 - 2025
  • DC State Medical License
    DC State Medical License 1982 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Phase II study: Induction chemotherapy and transoral surgery as definitive treatment (Tx) for locally advanced oropharyngeal squamous cell carcinoma (OPSCC)—An updat... 
    2019 ASCO Annual Meeting - 6/1/2019
  • Phase II study: Induction chemotherapy and transoral surgery as definitive treatment (Tx) for locally advanced oropharyngeal squamous cell carcinoma (OPSCC): A novel a... 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
  • Hematology and Medical Oncology Board Review Course 
    George Washington University, Washington, Dist Of Col - 8/15/2013

Press Mentions

  • Dr. Siegel on Benefits with Transoral Surgery and Chemotherapy for Head and Neck Cancer
    Dr. Siegel on Benefits with Transoral Surgery and Chemotherapy for Head and Neck CancerAugust 23rd, 2017
  • Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer
    Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal CancerAugust 22nd, 2017
  • Novel Regimen May Eliminate Need for Radiation in Some Oropharyngeal Cancers
    Novel Regimen May Eliminate Need for Radiation in Some Oropharyngeal CancersAugust 11th, 2017

Professional Memberships

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Anthem HealthKeepers HMO/POS
    Anthem KeyCare PPO
    BCBS Blue Card PPO
    CareFirst BCBS Maryland POS
    CareFirst BlueChoice Advantage
    CareFirst BlueChoice Network POS
    CareFirst BluePreferred PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    First Health PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment